John P. Parisot

1.4k total citations
18 papers, 802 citations indexed

About

John P. Parisot is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, John P. Parisot has authored 18 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in John P. Parisot's work include Research on Leishmaniasis Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Trypanosoma species research and implications (4 papers). John P. Parisot is often cited by papers focused on Research on Leishmaniasis Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Trypanosoma species research and implications (4 papers). John P. Parisot collaborates with scholars based in Australia, United Kingdom and United States. John P. Parisot's co-authors include Ian P. Street, John Zalcberg, Mario DeLuise, Jonathan B. Baell, Xiangdong Hu, Stephen B. Fox, Andrew Fellowes, Stephen Q. Wong, Alexander Dobrovic and Angela Tan and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

John P. Parisot

18 papers receiving 785 citations

Peers

Countries citing papers authored by John P. Parisot

Since Specialization

Citations

This map shows the geographic impact of John P. Parisot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Parisot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Parisot more than expected).

Fields of papers citing papers by John P. Parisot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Parisot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Parisot. The network helps show where John P. Parisot may publish in the future.

Co-authorship network of co-authors of John P. Parisot

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Parisot. A scholar is included among the top collaborators of John P. Parisot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Parisot. John P. Parisot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	“Cancer 2015”: A Prospective, Population-Based Cancer Cohort—Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic 2015 ·Journal of Personalized Medicine ·John P. Parisot, Heather Thorne, Andrew Fellowes, Ken Doig, Mark Lucas, John J. McNeil, Brett Doble, Alexander Dobrovic, Thomas John, Paul A. James, Lara Lipton, David M. Ashley, Theresa Hayes, Paul J. McMurrick, Gary Richardson, Paula Lorgelly, Stephen B. Fox, David M. Thomas	8
2	HIV-1 and Human PEG10 Frameshift Elements Are Functionally Distinct and Distinguished by Novel Small Molecule Modulators 2015 ·PLoS ONE ·Tony S. Cardno, (unknown), Brad E. Sleebs, Kurt Lackovic, John P. Parisot, (unknown), Caillan Crowe‐McAuliffe, (unknown), Christina D. Edgar, Torsten Kleffmann, Warren P. Tate	8
3	Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine 2015 ·Drug Discovery Today ·David M. Thomas, Stephen B. Fox, Paula Lorgelly, David M. Ashley, Gary Richardson, Lara Lipton, John P. Parisot, Mark Lucas, John J. McNeil	2
4	Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients 2015 ·British Journal of Cancer ·Stephen Q. Wong, Andrew Fellowes, (unknown), Jason Ellul, Trent J. Bosma, Debra E. Irwin, Ravikiran Vedururu, Angela Tan, Jonathan M. Weiss, Kian Sing Chan, Mark Lucas, David M. Thomas, Alexander Dobrovic, John P. Parisot, Stephen B. Fox	40
5	Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing 2014 ·BMC Medical Genomics ·Stephen Q. Wong, Jason Li, Angela Tan, Ravikiran Vedururu, Jia‐Min Pang, Hongdo Do, Jason Ellul, Ken Doig, Anthony Bell, Grant A. McArthur, Stephen B. Fox, David M. Thomas, Andrew Fellowes, John P. Parisot, Alexander Dobrovic, (unknown)	192
6	De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-X_L: Synthesis, Structural and Biochemical Characterization 2014 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Michael J. Roy, (unknown), Brian J. Smith, (unknown), (unknown), David C.S. Huang, John P. Parisot, Hong Yang, Ian P. Street, Peter M. Colman, Peter E. Czabotar, Jonathan B. Baell, Guillaume Lessène	30
7	An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery 2012 ·Disease Models & Mechanisms ·Lee Willoughby, (unknown), Samuel A. Manning, John P. Parisot, Ian P. Street, Helena E. Richardson, Patrick O. Humbert, Anthony M. Brumby	103
8	An Efficient High-Throughput Screening Method for MYST Family Acetyltransferases, a New Class of Epigenetic Drug Targets 2011 ·SLAS DISCOVERY ·Hendrik Falk, (unknown), Hong Yang, (unknown), (unknown), George Nikolakopoulos, Regina Surjadi, John D. Bentley, Meghan Hattarki, Olan Dolezal, James M. Murphy, Brendon J. Monahan, Thomas S. Peat, Tim Thomas, Jonathan B. Baell, John P. Parisot, Ian P. Street	35
9	Quinazoline Sulfonamides as Dual Binders of the Proteins B-Cell Lymphoma 2 and B-Cell Lymphoma Extra Long with Potent Proapoptotic Cell-Based Activity 2011 ·Journal of Medicinal Chemistry ·Brad E. Sleebs, Peter E. Czabotar, Wayne J. Fairbrother, W. Douglas Fairlie, John A. Flygare, David C.S. Huang, Wilhelmus J. A. Kersten, Michael F. T. Koehler, Guillaume Lessène, Kym N. Lowes, John P. Parisot, Brian J. Smith, Morey L. Smith, Andrew J. Souers, Ian P. Street, Hong Yang, Jonathan B. Baell	60
10	Discovery of novel and potent benzhydryl-tropane trypanocides highly selective for Trypanosoma cruzi 2010 ·Bioorganic & Medicinal Chemistry Letters ·Georgina A. Holloway, John P. Parisot, (unknown), (unknown), T. P. Armstrong, R.C.A. Thompson, Ian P. Street, Jonathan B. Baell	5
11	Inhibitors of Leishmania GDP-Mannose Pyrophosphorylase Identified by High-Throughput Screening of Small-Molecule Chemical Library 2010 ·Antimicrobial Agents and Chemotherapy ·Kurt Lackovic, John P. Parisot, (unknown), Jonathan B. Baell, Laurent Debien, Keith G. Watson, Joan Curtis, Emanuela Handman, Ian P. Street, Łukasz Kedzierski	32
12	Trypanothione Reductase High-Throughput Screening Campaign Identifies Novel Classes of Inhibitors with Antiparasitic Activity 2009 ·Antimicrobial Agents and Chemotherapy ·Georgina A. Holloway, William N. Charman, Alan H. Fairlamb, Reto Brun, Marcel Kaiser, Edmund Kostewicz, (unknown), John P. Parisot, J. Henry Richardson, Ian P. Street, Keith G. Watson, Jonathan B. Baell	52
13	Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening 2006 ·Bioorganic & Medicinal Chemistry Letters ·Georgina A. Holloway, Jonathan B. Baell, Alan H. Fairlamb, (unknown), John P. Parisot, J. Henry Richardson, Keith G. Watson, Ian P. Street	42
14	Tyrosine kinase inhibitors from the rainforest tree Polyscias murrayi 2005 ·Phytochemistry ·Malcolm S. Buchanan, Anthony R. Carroll, (unknown), John P. Parisot, Rama Addepalli, Ronald J. Quinn	8
15	MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines 2000 ·Prostate Cancer and Prostatic Diseases ·John Zalcberg, (unknown), (unknown), John P. Parisot, Assam El‐Osta, Phillip Kantharidis, (unknown), (unknown)	63
16	Induction of insulin‐like growth factor binding protein expression by ICI 182,780 in a tamoxifen‐resistant human breast cancer cell line 1999 ·Breast Cancer Research and Treatment ·John P. Parisot, Kerri S. Leeding, Xiu Feng Hu, Mario DeLuise, John Zalcberg, Leon A. Bach	19
17	Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line 1999 ·British Journal of Cancer ·John P. Parisot, Xiangdong Hu, Mario DeLuise, John Zalcberg	71
18	The pure antiestrogen ICI 182,780 binds to a high‐affinity site distinct from the estrogen receptor 1995 ·International Journal of Cancer ·John P. Parisot, Xiu Feng Hu, (unknown), Alan E. Wakeling, John Zalcberg, Mario DeLuise	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact